AQEMIA

Aqemia is revolutionizing the field of drug discovery with its unique blend of quantum-inspired physics and machine learning. Established in 2019, Aqemia aims to exponentially scale the drug discovery process by generating its own data through proprietary quantum physics algorithms, developed over 12 years of research. This self-generated data efficiently guides Aqemia's generative AI, enabling the discovery of therapeutic molecules at a speed 10,000 times faster than traditional methods. With a team of over 50 experts and numerous collaborations with major pharmaceutical companies, Aqemia is actively shaping the future of medicine.

Aqemia's platform is designed to handle multiple drug discovery projects simultaneously, ensuring scalability and meeting industry demands. The technology is applied in hit generation, in vivo assays, and collaborative projects with pharmaceutical companies, demonstrating its vast potential applications. Aqemia's platform caters to pharmaceutical companies, biotech firms, and research institutions, all seeking to leverage cutting-edge technology for faster and more accurate drug discovery.